Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.

Slides:



Advertisements
Similar presentations
Antimicrobial Prescribing in the Management of COPD
Advertisements

Infections in the Immunocompromised Host
Antimicrobial Prophylaxis in Neutropenic Adult Oncology Outpatients ASCO Clinical Practice Guideline.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Daniel Urschel, MD, Charles Pace, MD, Sherman Alter, MD
Neonatal Sepsis Sepsis neonatorum is the term used to describe any systemic bacterial infection any systemic bacterial infection documented by a Positive.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
Pneumonia: nursing management Islamic University Nursing College.
MINOR CRITERIAA RESPIRATORY RATEB _30 BREATHS/MIN PAO2/FIO2 RATIOB _250 MULTILOBAR INFILTRATES CONFUSION/DISORIENTATION UREMIA (BUN LEVEL, _20 MG/DL) LEUKOPENIAC.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Click the mouse button or press the space bar to display information. A Guide to Communicable Respiratory Diseases Communicable diseases can be spread.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Community Acquired Pneumonia in Children June 2014 Pediatric Continuity Clinic Curriculum Created by: Cecile Besingi.
Pneumonia and Sepsis By Oliver Putt and Priyanca Patel For WMS Peer Support – 11 th November 2014.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
An Approach To Community Acquired Pneumonia Laura Miles, Pediatrics Resident Otto Vanderkooi, Infectious Disease Specialist.
Community Acquired Pneumonia Dr Sanjay Lalwani Vice Principal Professor and Head Department Pediatrics BVUMC, Pune 26/07/2015
The Importance of Viral Etiology in Hospitalized Patients with Community Acquired Pneumonia in Jefferson County Martin Gnoni MD, Swetha Kadali, MD, Jorge.
François Boucher MD, FRCPC Community acquired pneumonia (CAP): Why is this still a problem?
PHARMACOLOGY CONFERENCE
Insert Program or Hospital Logo Introduction The Respiratory Syncytial virus (RSV) was discovered in 1956 and has been since recognized as one of the most.
Plans for Diagnosis of Community Acquired Pneumonia.
 At the end of the lecture, students should :  Describe briefly common types of meningitis  Describe the principles of treatment  List the name of.
INF 1 ® Life-Threatening Infections INF 1 ®. INF 2 ® Objectives Recognize predisposing conditions for infection Identify clinical manifestations of infection.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Development of Antibiotics for Otitis Media: Past, Present, and Future Janice Soreth, M.D. Director Division of Anti-Infective Drug Products.
Bacterial Pneumonia.
Life-Threatening Infections: Diagnosis and Antimicrobial Therapy Selection.
MANAGEMENT FOR PAEDIATRIC PATIENT UNDER INVESTIGATION (PUI) WITH INFLUENZA-LIKE ILLNESS (ILI) IN OUTPATIENT SETTING CM CHOO HSAH 2013.
Avian Influenza H5N1 Prepared by: Samia ALhabardi.
Morning Report August 9, 2010.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
How Clinicians Use Data For Clinical Decision Making March 5, 2003 Anti-Infective Drug Advisory Committee How Clinicians Use Data For Clinical Decision.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
TREATMENT OF SEVERE PNEUMONIA WITH ORAL ANTIBIOTICS Lozano JM, on behalf of the APPIS Trial Group. Department of Pediatrics and Clinical Epidemiology Unit,
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
Case Discussion CMID Outline Epidemiology Clinical presentation Management: -Investigations -Antimicrobial therapy -Adjunct therapy Complications.
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
Prevalence of Bacteremia in Low Risk Patients with Sickle Cell Disease and Fever Shashidhar Marneni, MD Fellow(1 st Year) Pediatric Emergency Medicine.
Management: Patient Diagnostics: CBC and PC to check for infection, Chest X ray IVF: D5IMB to run at 35 ml/hr Medications: 1. NSS nebulization 2 ml q6h.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
IDSA CLINICAL PRACTICE GUIDELINE FOR ACUTE BACTERIAL RHINOSINUSITIS IN CHILDREN AND ADULTS CLINICAL INFECTIOUS DISEASES ADVANCE ACCESS PUBLISHED MARCH.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
PRINCIPLES OF ANTIBIOTIC THERAPY
ABDULLAH M. AL-OLAYAN MBBS, SBP, ABP. ASSISTANT PROFESSOR OF PEDIATRICS. PEDIATRIC PULMONOLOGIST. PNEUMONIA.
An infiltrate on chest radiograph supports the diagnosis of pneumonia
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
Community Acquired Pneumonia
FEVER WITHOUT LOCALIZING SIGNS
Pneumonia Salutations:
Drugs used in Meningitis Prof. Azza ELMedany
CAP Irfan Shafi  PGY 1  1885,  Dr. Holtzapple administered oxygen to 16-year-old Pt with pneumonia.
Bronchiolitis Clinical Practice Guideline QI Project
The challenges of multi-drug-resistance in hepatology
Neonatal sepsis in Kilifi
بنام خداوند جان و خرد بنام خداوند جان و خرد.
BY ABDULJALEEL ELSHALWI MAHMOUD ELMABRI ANTIBIOTICS PROTOCOLS IN A NEONATAL INTENSIVE CARE UNITE OF AL-WAHDA HOSPITAL DERNA.
Ordering Sputum Cultures in Community Acquired Pneumonia
Community Acquired Pneumonia
Pneumonia in Children Dr Montaha AL-Iede, MD,DCH,FRACP
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
Empiric antibiotic therapy
CDC-recommended regimens for intrapartum antibiotic prophylaxis for prevention of early-onset GBS disease. CDC-recommended regimens for intrapartum antibiotic.
Presentation transcript:

Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim

SITE-OF-CARE MANAGEMENT DECISIONS When Does a Child or Infant With CAP Require Hospitalization? 1. Children and infants who have moderate to severe CAP, as defined by several factors, including respiratory distress and hypoxemia should be hospitalized for management, including skilled pediatric nursing care. (strong recommendation; high-quality evidence)

DIAGNOSTIC TESTING FOR PEDIATRIC CAP What Diagnostic Laboratory and Imaging Tests Should Be Used in a Child With Suspected CAP? Blood Cultures: Inpatient 14. Blood cultures should be obtained in children requiring hospitalization for presumed bacterial CAP that is moderate to severe, particularly those with complicated pneumonia. (strong recommendation; low-quality evidence)

Testing For Viral Pathogens 21. Antibacterial therapy is not necessary for children, either outpatients or inpatients, with a positive test for influenza virus in the absence of clinical, laboratory, or radiographic findings that suggest bacterial coinfection. (strong recommendation; high-quality evidence). 22. Testing for respiratory viruses other than influenza virus can modify clinical decision making in children with suspected pneumonia, because antibacterial therapy will not routinely be required for these children in the absence of clinical, laboratory, or radiographic findings that suggest bacterial coinfection. (weak recommendation; low-quality evidence)

Complete Blood Cell Count 25. Routine measurement of the complete blood cell count is not necessary in all children with suspected CAP managed in the outpatient setting, but in those with more serious disease it may provide useful information for clinical management in the context of the clinical examination and other laboratory and imaging studies. (weak recommendation; low-quality evidence) Acute-Phase Reactants 27. Acute-phase reactants, such as the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) concentration, or serum procalcitonin concentration, cannot be used as the sole determinant to distinguish between viral and bacterial causes of CAP. (strong recommendation; high- quality evidence)

Initial Chest Radiographs: Inpatient 33. Chest radiographs (posteroanterior and lateral) should be obtained in all patients hospitalized for management of CAP to document the presence, size, and character of parenchymal infiltrates and identify complications of pneumonia that may lead to interventions beyond antimicrobial agents and supportive medical therapy. (strong recommendation; moderate-quality evidence) Follow-up Chest Radiograph 35. Repeated chest radiographs should be obtained in children who fail to demonstrate clinical improvement and in those who have progressive symptoms or clinical deterioration within 48–72 hours after initiation of antibiotic therapy. (strong recommendation; moderate-quality evidence)

ANTI-INFECTIVE TREATMENT Inpatients 46. Ampicillin or penicillin G should be administered to the fully immunized infant or school-aged child admitted to a hospital ward with CAP when local epidemiologic data document lack of substantial high-level penicillin resistance for invasive S. pneumoniae. (strong recommendation; moderate-quality evidence)

47. Empiric therapy with a third-generation parenteral cephalosporin (ceftriaxone or cefotaxime) should be prescribed for hospitalized infants and children who are not fully immunized, in regions where local epidemiology of invasive pneumococcal strains documents high-level penicillin resistance, or for infants and children with life- threatening infection, including those with empyema. (weak recommendation; moderate-quality evidence) 49. Vancomycin or clindamycin (based on local susceptibility data) should be provided in addition to b-lactam therapy if clinical, laboratory, or imaging characteristics are consistent with infection caused by S. aureus. (strong recommendation; low-quality evidence)